Trince
@trincebio.com
Discover a gentler cell transfection method. LumiPoreTM by Trince Bio provides precision transformation for improved cell viability and faster recovery.
Trince's Company Logos
Trince's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1E73BE
Mariner
30, 115, 190
208, 73, 43
84, 39, 0, 25
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#222222
Mine Shaft
34, 34, 34
0, 0, 13
0, 0, 0, 87
About Trince
Trince is a Ghent University spin-off company with a mission to revolutionize cell-based therapies through gentler transfections. The company was officially founded in December 2021, following several years of academic research. Trince offers an effective alternative transfection method to viral vectors and electroporation, using their gentle photoporation technology.
They aim to be active in all areas where physical transfection can contribute to more efficient cell engineering, from research and development to clinical applications. Trince's technology can be used within GMP and manufacturing settings, as well as in tissue and stem cell engineering. Their primary focus is on applications such as cell and gene therapy, positioning their gentle photoporation technology for use in GMP-compliant clinical settings.
With a dedicated team, including experienced entrepreneurs, scientists, and engineers, Trince is at the forefront of advancing cell-based therapies. The company has also received support from partners and investors such as Novalis Biotech, further validating their innovative approach in the life sciences industry
